Early administration of the GIP receptor antagonist (Pro(3))GIP counters development of hyperglycaemia, glucose intolerance and insulin resistance in genetic obesity

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)0171
JournalDiabetologia
Volume49
Issue numberSuppl.
Publication statusPublished - Sep 2006

Cite this